Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Convalescent Plasma vs Human Immunoglobulin for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Trial

NCT04381858 is registered in ClinicalTrials.gov with Centenario Hospital Miguel Hidalgo as lead sponsor.

NCT NCT04381858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04381858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Convalescent Plasma vs Human Immunoglobulin for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Trial
Lead sponsor
Centenario Hospital Miguel Hidalgo
Phase
Phase 3
Overall status
Completed
Start date
May 6, 2020
Completion date
November 26, 2020
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia